G-DEFINER retweeted
#Postdoc position available on #sarcoma #Immunity at Molecular Pharmacology of @IstTumori - if interested please contact [email protected]
Replying to @GDefiner
@GDefiner project investigated the #gender inequalities among #cancer patients in the development of immune-related adverse events associated with #immunotherapy treatment across 4 countries 🇮🇹🇸🇪🇳🇴🇮🇪 Presentation of study outcomes👉📺 t.ly/czQ4W
Delighted to meet at closing meeting of @GDefiner and @GENDER_NET_Plus . Great meeting and lots of results to come!
G-DEFINER retweeted
Replying to @TSDocBaddie
Yes; categorization completely arbitrary; quintiles are demographic not biologic; hides any steep part of the risk curve. Outer quintiles are very heterogeneous. Show the risk curve as a function of relative food volume. #bbrcourse #rmscourse discourse.datamethods.org/t/…
G-DEFINER retweeted
Interesting discussion about adjuvant treatment in extremity STS at ISG annual meeting…food for thoughts and new idea for an upcoming trial! Stay tuned…@alegronchi @annamariafrezza @SilviaStacchia @casali_pg @apdeitos @sandro_pasquali @Robertasanfili @ctosociety – at Rozzano, Lombardia
G-DEFINER retweeted
Abstract submission is now open for #BRIDGES2022!
The conference BRIDGES BETWEEN DISCIPLINES: GENDER IN STEM AND SOCIAL SCIENCES is a hybrid (on-site + online) event to be held on September 12-16, 2022. More information: bridges2022.com/registration…
#Intersectionality #GenderBias
Dear Twitter, listen to 🇮🇪 🇮🇹🇳🇴🇸🇪@GDefiner coordinator Ros @AlbaMiceli and find out more on #Cancer therapy and sex & #gender inequalities in immune-related adverse events with immunotherapy treatment 👇 RT welcome 📣
youtu.be/qcxP_31tK1M
“Female researchers are more read and less cited because they more often engage in research for societal progress.”
blogs.lse.ac.uk/impactofsoci…
Replying to @ProfJohnCrown
@GDefiner identifying how gender plays a role in how people have adverse immune related events associated with their immunotherapy.
Replying to @ProfJohnCrown
Is there a way we can make the immunotherapy results in metastatic uveal melanoma better? @Dr_Alex_Eustace and the @CCRTIreland team are also trying to explain gender differences in immunotherapy as part of the international @G-Definer study.
We are also collaborating with other international colleagues on the G-Definer study looking at gender differences in immunotherapy outcomes. @Dr_Alex_Eustace is leading our effort here.
G-DEFINER retweeted
Replying to @ProfJohnCrown
@GDefiner identifying how gender plays a role in how people have adverse immune related events associated with their immunotherapy.
Gender medicine support
m.facebook.com/lastampa.it/p…



















